Advanced in B-Cell Lymphoma

Hans Hagberg

Uppsala, C, SE 
Advanced in B-Cell Lymphoma
Uppsala, C, SE 
OverviewLocationsClinical Research

Overview

Hans Hagberg practices in Uppsala, Sweden. Mr. Hagberg is rated as an Advanced expert by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Follicular Lymphoma, and Bone Marrow Transplant.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles and participated in 1 clinical trial in the study of B-Cell Lymphoma.

Gender
Male

Locations

Uppsala, C, Sweden
Other Locations
Stockholm, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy - a Phase II Trial.
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy - a Phase II Trial.
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Biological
Study Drug: CD19-Targeted CAR-T Cells
Study Phase: Phase 2
Follow-up of Malignancies in Transplanted Patients
Follow-up of Malignancies in Transplanted Patients
Enrollment Status: Completed
Publish Date: October 26, 2017
Intervention Type: Drug, Other
View 1 Less Clinical Trial

34 Total Publications

Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden.
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden.
Journal: Leukemia
Published: December 15, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hagberg's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile